New York Integrative Psychiatry launches ketamine-assisted psychotherapy in Manhattan

New York Integrative Psychiatry is offering in-person ketamine-assisted psychotherapy from its Manhattan office for patients with treatment-resistant depression, anxiety, PTSD and related conditions. The practice says the model combines ketamine with psychotherapy and is available to patients across New York City, including Brooklyn, Queens and the Bronx.

Why it matters: - Ketamine-assisted psychotherapy gives patients with treatment-resistant mental health conditions another option when standard medication and talk therapy have not worked. - The practice says the model is designed to support symptom relief and deeper therapeutic change, not just short-term relief. - The service is available in Manhattan and to patients across New York City.

What happened: - New York Integrative Psychiatry announced ketamine-assisted psychotherapy services in Manhattan on July 16, 2026. - The practice offers KAP to patients living with treatment-resistant depression, anxiety, PTSD and other mental health conditions. - Services are provided in person at the practice’s Manhattan office at 111 W 24th St., Suite 300, New York, NY 10011.

The details: - Ketamine is described as a dissociative anesthetic that has been used in surgical and emergency medicine for decades. - The practice says ketamine has gained recognition for off-label use in mental health care, including depression, anxiety, PTSD and substance use disorders. - Ketamine works by affecting the brain’s glutamate system and enhancing neuroplasticity, creating a window for shifts in mood, thinking and behavior. - KAP combines ketamine with psychotherapy and is delivered as a structured model rather than a standalone treatment. - Dosing is individualized based on a patient’s sensitivity, treatment response and personal preferences. - The practice’s team has specialized training in psychedelic-assisted therapy and uses the principles of set, setting and support. - Dr. Ben Medrano, spokesperson for New York Integrative Psychiatry, said the practice saw a need for treatments that go beyond symptom management and support meaningful psychological healing. - Dr. Medrano said patients typically begin with an evaluation, then move through preparation sessions, ketamine-assisted sessions with therapeutic support and integration work. - Dr. Medrano said the practice emphasizes psychiatric evaluation, individualized treatment planning and integration-focused psychotherapy. - Dr. Ben Medrano is a board-certified psychiatrist specializing in Integrative Psychiatry, Ketamine Assisted Therapy and Psychedelic Harm Reduction and Integration. - New York Integrative Psychiatry is certified by LegitScript. - A patient testimonial in the release said the practice’s team has been “lovely and compassionate” and has helped the patient “immeasurably” over more than four years. - The practice says its care model includes psychiatrists, nurse practitioners, medical providers and therapists working together. - The practice also offers psychiatric care, psychotherapy, medication management and mindfulness-based interventions.

Between the lines: - The release positions KAP as part of a broader shift in mental health care toward treatments that pair biological intervention with psychotherapy. - The emphasis on selection criteria suggests the practice is framing KAP as a targeted option for patients who are motivated for self-exploration and open to experiential work. - The broader claim is that some patients may experience changes not only in symptoms, but also in self-compassion, meaning and how they relate to their emotions and life experiences.

What's next: - Patients interested in learning more can visit the practice’s website. - Interview requests and additional information are available through the contact page. - The practice’s service area includes New York City neighborhoods and boroughs, with care centered at its Manhattan office.

The bottom line: - New York Integrative Psychiatry is using ketamine-assisted psychotherapy to expand treatment options for patients with hard-to-treat depression, anxiety and PTSD, with a model built around individualized dosing and psychotherapy support.